<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04607668</url>
  </required_header>
  <id_info>
    <org_study_id>G1T28-207</org_study_id>
    <nct_id>NCT04607668</nct_id>
  </id_info>
  <brief_title>Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):</brief_title>
  <acronym>PRESERVE1</acronym>
  <official_title>PRESERVE 1: A Phase 3 Randomized, Double-blind Trial of Trilaciclib Versus Placebo in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>G1 Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>G1 Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled, global, multicenter, Phase 3 trial&#xD;
      evaluating the impact of trilaciclib on myelopreservation and anti-tumor efficacy when&#xD;
      administered prior to FOLFOXIRI/bevacizumab in patients with pMMR/MSS mCRC who have not&#xD;
      received systemic therapy for metastatic disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomly assigned (1:1) to receive placebo or trilaciclib on Days 1 and 2&#xD;
      administered intravenously (IV) prior to FOLFOXIRI/bevacizumab in 14-day cycles for up to 12&#xD;
      cycles (Induction).&#xD;
&#xD;
      Following completion of Induction, patients will continue in Maintenance, where they will&#xD;
      receive trilaciclib or placebo per randomization allocation at study entry.&#xD;
      Trilaciclib/placebo will be administered prior to infusional-5FU/leucovorin/bevacizumab at&#xD;
      the same dose and schedule used during Induction. The patient may continue to receive&#xD;
      treatment on study until disease progression, unacceptable toxicity, withdrawal of consent,&#xD;
      discontinuation by Investigator, or the end of the trial, whichever occurs first. Treatment&#xD;
      cycles will occur consecutively without interruption, except when necessary to manage&#xD;
      toxicities or for administrative reasons.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 25, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-Blinded Trial</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Myelopreservation</measure>
    <time_frame>Through Induction Period- on average 24 weeks (up to 12 cycles) of FOLFOXIRI/bevacizumab</time_frame>
    <description>To assess the effects of trilaciclib on the neutrophil lineage compared with placebo in patients receiving FOLFOXIRI/bevacizumab for pMMR/MSS mCRC as measured by duration of severe [Grade 4] neutropenia [DSN] in Cycle 1 and occurrence of severe neutropenia [SN] during Induction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life/ Effects on Chemotherapy-Induced Fatigue</measure>
    <time_frame>Through Induction Period- on average 24 weeks (up to 12 cycles) of FOLFOXIRI/bevacizumab</time_frame>
    <description>To assess the effects of trilaciclib on chemotherapy-induced fatigue compared with placebo in patients receiving FOLFOXIRI/bevacizumab for pMMR/MSS mCRC, as measured by Time To First Confirmed Deterioration of Fatigue (TTCD-fatigue) during Induction, as measured by the FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti-tumor Efficacy</measure>
    <time_frame>From date of randomization until date of documented radiologic disease progression per RECIST v1.1 or death due to any cause, whichever comes first</time_frame>
    <description>To assess the effect of trilaciclib on Progression Free Survival (PFS) compared with placebo in patients receiving FOLFOXIRI/bevacizumab for pMMR/MSS mCRC as measured by Radiographic PFS (per RECIST 1.1) and OS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anti-tumor Efficacy</measure>
    <time_frame>From date of randomization until date of death due to any cause</time_frame>
    <description>To assess the effect of trilaciclib on Overall Survival (OS) compared with placebo in patients receiving FOLFOXIRI/bevacizumab for pMMR/MSS mCRC as measured by Radiographic PFS (per RECIST 1.1) and OS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">296</enrollment>
  <condition>Colorectal Cancer Metastatic</condition>
  <condition>Myelosuppression-Adult</condition>
  <condition>Chemotherapeutic Toxicity</condition>
  <arm_group>
    <arm_group_label>trilaciclib + FOLFOXIRI/bevacizumab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During Induction the following study drugs are administered on Day 1:&#xD;
Irinotecan- IV Oxaliplatin - IV Leucovorin- IV Fluorouracil - continuous infusion (CI) over 48 hours beginning on Day 1; Bevacizumab - IV&#xD;
Following completion of Induction, patients will continue in Maintenance, where they will continue to receive trilaciclib per randomization allocation. Trilaciclib will be administered prior to infusional-5FU/leucovorin/bevacizumab at the same dose and schedule used during Induction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo + FOLFOXIRI/bevacizumab</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The subjects in the placebo arm will follow the same schedule as the trilaciclib arm, but will receive placebo instead of trilaciclib</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trilaciclib</intervention_name>
    <description>Trilaciclib or placebo</description>
    <arm_group_label>trilaciclib + FOLFOXIRI/bevacizumab</arm_group_label>
    <other_name>G1T28</other_name>
    <other_name>CDK 4/6 inhibitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>dextrose 5% in water or normal saline (sodium chloride solution 0.9%)</description>
    <arm_group_label>placebo + FOLFOXIRI/bevacizumab</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Selected Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥ 18 years of age at the time of signing the informed consent. Patients &gt; 70 years&#xD;
             of age must have a G8 Health State Screening Tool (geriatric screening tool) score &gt;.&#xD;
&#xD;
          2. Proficient mismatch repair/microsatellite stable (pMMR/MSS), histologically or&#xD;
             cytologically-confirmed adenocarcinoma of the colon or rectum. Patients with any BRAF&#xD;
             or KRAS mutation status are eligible.&#xD;
&#xD;
          3. Unresectable and measurable or evaluable disease per RECIST v1.1&#xD;
&#xD;
          4. ECOG performance status of 0 to 1&#xD;
&#xD;
          5. A formalin-fixed paraffin-embedded (FFPE) tumor specimen (from archival or fresh&#xD;
             biopsy) with an associated pathology report documenting pMMR/MSS mCRC must be&#xD;
             confirmed to be available to send to the Sponsor for planned retrospective biomarker&#xD;
             analyses.&#xD;
&#xD;
          6. Adequate organ function&#xD;
&#xD;
        Selected Exclusion Criteria:&#xD;
&#xD;
          1. Prior systemic therapy for mCRC. Patients who received adjuvant/neoadjuvant therapy&#xD;
             (ie, treatment with curative intent) for colorectal cancer are eligible if it has been&#xD;
             ≥ 6 months between the last dose of systemic chemotherapy and the date of informed&#xD;
             consent.&#xD;
&#xD;
          2. Any radiotherapy, chemotherapy, immunotherapy, biologic, investigational, or hormonal&#xD;
             therapy for cancer treatment (except for adjuvant hormonal therapy for breast cancer&#xD;
             or prostate cancer defined as M0 disease or PSA persistence/recurrence without&#xD;
             metastatic disease) within 3 weeks prior to the first dose of trilaciclib/placebo.&#xD;
&#xD;
          3. Receipt of any low-dose systemic chemotherapeutic agent (e.g., low-dose methotrexate&#xD;
             for rheumatoid arthritis) administered for a nononcologic purpose within 3 weeks prior&#xD;
             to the first dose of trilaciclib/placebo.&#xD;
&#xD;
          4. Presence of central nervous system (CNS) metastases/leptomeningeal disease requiring&#xD;
             immediate treatment with radiation therapy or steroids&#xD;
&#xD;
          5. QTcF interval &gt; 450 msec (males) or &gt; 470 msec (females) at screening. For patients&#xD;
             with ventricular pacemakers, QTcF &gt; 500 msec.&#xD;
&#xD;
          6. Personal or family history of long QT syndrome&#xD;
&#xD;
          7. Symptomatic peripheral neuropathy&#xD;
&#xD;
          8. History of interstitial lung disease (ILD)&#xD;
&#xD;
          9. Prior allogeneic or autologous hematopoietic stem cell or bone marrow transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Contact</last_name>
    <role>Study Director</role>
    <affiliation>G1 Therapeutics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>G1Therapeutics Clinical Contact</last_name>
    <phone>919-213-9835</phone>
    <email>clinicalinfo@g1therapeutics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AZ Oncology Associates - HOPE</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85711</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benito Gomez</last_name>
      <phone>520-886-0206</phone>
      <email>benito.gomez@mckesson.com</email>
    </contact>
    <contact_backup>
      <last_name>Terry Patton</last_name>
      <phone>(520)886-0206</phone>
      <email>terry.patton@mckesson.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sudhir Manda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Pennington</last_name>
      <phone>520-694-9065</phone>
      <email>danielpennington@email.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Aaron Scott</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beverly Hills Cancer Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Obrastoff</last_name>
      <phone>310-432-8933</phone>
      <email>aobrastoff@bhcancercenter.com</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Gabayan, PharmD</last_name>
      <phone>310-432-8933</phone>
      <email>jlavi@bhcancercenter.com</email>
    </contact_backup>
    <investigator>
      <last_name>Afshin E. Gabayan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keck Medical Center of USC Pasadena</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charleen Ketchens</last_name>
      <phone>323-865-3035</phone>
      <email>ketchens_c@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Heinz Lenz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Oncology Institute of Hope &amp; Innovation\ Innovative Clinical Research Institute</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irving Ledesma</last_name>
      <phone>562-693-4477</phone>
      <email>iledesma@icrinstitute.com</email>
    </contact>
    <contact_backup>
      <last_name>Danielle Mendoza</last_name>
      <phone>562-693-4477</phone>
      <email>dmendoza@icrinstitute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Omkar Marathe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health - Memorial Hospital</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia Deschaine</last_name>
      <phone>719-365-6855</phone>
      <email>alicia.deschaine@uchealth.org</email>
    </contact>
    <investigator>
      <last_name>Robert Hoyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgetown University - Lombardi Comprehensive Cancer Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghan Mavredes</last_name>
      <phone>202-444-2223</phone>
      <email>mm4780@georgetown.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joseph Young</last_name>
      <phone>202-444-2223</phone>
      <email>jy620@georgetown.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin Weinberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists (South Region)</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33916</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrice Cowan</last_name>
      <phone>239-274-9930</phone>
      <email>pcowan@flcancer.com</email>
    </contact>
    <contact_backup>
      <last_name>Donna Bernard</last_name>
      <phone>239-274-9930</phone>
      <phone_ext>26867</phone_ext>
      <email>donna.bernard@flcancer.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anjan Jayantilal Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists NORTH</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33916</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cara OKeefe</last_name>
      <phone>239-274-8200</phone>
      <phone_ext>125</phone_ext>
      <email>cokeefe@flcancer.com</email>
    </contact>
    <investigator>
      <last_name>Maen Hussein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jeremy Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid-Florida Hematology &amp; Oncology Centers, P.A.</name>
      <address>
        <city>Orange City</city>
        <state>Florida</state>
        <zip>32763</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Velez</last_name>
      <phone>386-774-1223</phone>
      <phone_ext>151</phone_ext>
      <email>avelez@aorcorp.com</email>
    </contact>
    <contact_backup>
      <last_name>Mahesh Nelakurthi</last_name>
      <phone>386-742-7191</phone>
      <email>mahesh@aorcorp.com</email>
    </contact_backup>
    <investigator>
      <last_name>Santosh Nair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenifer Bar-Nur</last_name>
      <phone>561-472-1696</phone>
      <email>jbar-nur@flcancer.com</email>
    </contact>
    <investigator>
      <last_name>Guillermo Abesada-Terk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists - Panhandle</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelia Gagne</last_name>
      <phone>850-877-8166</phone>
      <email>sgagne@flcancer.com</email>
    </contact>
    <contact_backup>
      <last_name>Patty Wright</last_name>
      <phone>850-877-8166</phone>
      <email>pwright@flcancer.com</email>
    </contact_backup>
    <investigator>
      <last_name>Viralkumar K Bhanderi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AdventHealth Digest. Health</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Carr</last_name>
      <phone>813-615-7068</phone>
      <email>christopher.carr@adventhealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Eliot Gaurkee</last_name>
      <phone>813-615-7200</phone>
      <phone_ext>52201</phone_ext>
      <email>eliot.gaurkee@adventhealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>Allen Chudzinski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northside Hospital - Georgia Cancer Specialists</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Haislip</last_name>
      <phone>770-496-9457</phone>
      <email>sally.haislip@gacancer.com</email>
    </contact>
    <investigator>
      <last_name>Rodolfo Bordoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Jenkins</last_name>
      <phone>706-721-1206</phone>
      <email>kejenkins@augusta.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ashlyn Stevenson</last_name>
      <phone>706-721-0660</phone>
      <email>asstevenson@augusta.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Asha Nayak-Kapoor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Cancer Specialists</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Patton</last_name>
      <phone>847-259-4482</phone>
    </contact>
    <contact_backup>
      <last_name>Laura Palmisano</last_name>
      <phone>(847) 259-4482</phone>
      <email>laura.palmisano@usoncology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard Siegel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mary Bird Perkins Cancer Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Smith</last_name>
      <phone>225-214-6336</phone>
      <email>mmsmith@marybird.com</email>
    </contact>
    <contact_backup>
      <last_name>Adrian Beckwith</last_name>
      <phone>225-215-1370</phone>
      <email>abeckwith@marybird.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Hanson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Medina</last_name>
      <phone>617-638-6256</phone>
      <email>thomas.medina@bmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Anthony Shelton</last_name>
      <phone>617-638-5612</phone>
      <email>anthony.shelton@bmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Matthew Kulke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsey Allen</last_name>
      <phone>774-455-4446</phone>
      <email>lindsey.allen@umassmed.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dawn Pepka-Jones</last_name>
      <phone>774-455-4451</phone>
      <email>dawn.pepka-jones@umassmemorial.org</email>
    </contact_backup>
    <investigator>
      <last_name>Tasneem Ali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nhi Baltazar</last_name>
      <phone>507-422-6953</phone>
      <email>baltazar.nhi@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Joleen Hubbard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Louis Cancer Care, LLP</name>
      <address>
        <city>Bridgeton</city>
        <state>Missouri</state>
        <zip>63044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelli Martin, RN, BSN,CCRC</last_name>
      <phone>314-291-3312</phone>
      <phone_ext>2205</phone_ext>
      <email>KMartin@stlouiscancercare.com</email>
    </contact>
    <investigator>
      <last_name>J. Daniel Cuevas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Midwest Ventures Group, Inc d/b/a HCA MidAmerica Division, LLC</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Schroeder</last_name>
      <phone>816-276-3630</phone>
      <email>molly.schroeder2@hcamidwest.com</email>
    </contact>
    <contact_backup>
      <last_name>Shannon Cone</last_name>
      <phone>816-276-3890</phone>
      <email>shannon.cone@hcamidwest.com</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Stilwill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comp. Cancer Centers of Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Duong</last_name>
      <phone>702-952-3400</phone>
      <email>amy.duong@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Fadi Braiteh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nabeel Badri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pannaga Malalur</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Yarbrough</last_name>
      <phone>405-271-8777</phone>
      <email>melissa-yarbrough@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Sagila George, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tasha Gingerich</last_name>
      <phone>503-494-0851</phone>
      <email>gingerit@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anna Jackson</last_name>
      <phone>5034945165</phone>
      <email>breuer@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Emerson Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gettysburg Cancer Center</name>
      <address>
        <city>Gettysburg</city>
        <state>Pennsylvania</state>
        <zip>17325</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Burke</last_name>
      <phone>717-334-4033</phone>
      <phone_ext>131</phone_ext>
      <email>terry@gettysburgoncology.com</email>
    </contact>
    <contact_backup>
      <last_name>Vanessa Warner</last_name>
      <phone>717-334-4033</phone>
      <email>vwarner@gettysburgoncology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Satish Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennessee Oncology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Parcescu</last_name>
      <phone>615-329-7274</phone>
      <email>cristina.parcescu@sarahcannon.com</email>
    </contact>
    <investigator>
      <last_name>David Spigel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Oncology-Baylor Sammons</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Patton</last_name>
      <phone>214-370-1000</phone>
      <email>terry.patton@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Scott Paulson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberli Crane</last_name>
      <phone>214-648-7029</phone>
      <email>kimberli.crane@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Syed Kazmi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Millennium Oncology</name>
      <address>
        <city>Kingswood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Waldron</last_name>
      <phone>877-870-2640</phone>
      <email>jwaldron@wmrad.com</email>
    </contact>
    <investigator>
      <last_name>Krishna Pachipala</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Schar Cancer Institute</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Wardlow</last_name>
      <phone>571-472-1070</phone>
      <email>raymond.wadlow@inova.org</email>
    </contact>
    <investigator>
      <last_name>Timothy Cannon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Oncology Associates</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Holliman</last_name>
      <phone>757-873-9810</phone>
      <email>adrian.holliman@usoncology.com</email>
    </contact>
    <contact_backup>
      <last_name>Amanda Hudgins</last_name>
      <phone>(757)873-9810</phone>
      <email>amanda.hudgins@usoncology.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Chang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onc and Hem Assoc of SW VA</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Patton</last_name>
      <phone>540-982-0237</phone>
    </contact>
    <investigator>
      <last_name>Mark Kochenderfer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Cancer Hospital</name>
      <address>
        <city>Zijingshan</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Wang Jufeng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuhan Union Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tao Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jilin Provincial Tumor Hospital</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ying Cheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zulong Zheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Haijun Zhong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Tumor Hospital of Harbin Medical University</name>
      <address>
        <city>Heilongjiang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yanqiao Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jinan Central hospital</name>
      <address>
        <city>Shandong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Meili Sun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tianshu Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xuzhou Central hospital</name>
      <address>
        <city>Xuzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yuan Yuan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Yanru Qin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orszagos Onkologiai Intezet</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Nagy</last_name>
      <phone>+36203424934</phone>
      <email>petra.nagy@coordination.hu</email>
    </contact>
    <investigator>
      <last_name>Erika Hitre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Sirokaine Dezso</last_name>
      <phone>+36304143458</phone>
      <email>dezso.maria@med.unideb.hu</email>
    </contact>
    <investigator>
      <last_name>Peter Arosky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Petz Aladar Megyei Oktato Korhaz</name>
      <address>
        <city>Gyor</city>
        <zip>9024</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Istvan Sipocz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bela Piko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bacs-Kiskun Megyei Oktatokorhaz</name>
      <address>
        <city>Kecskemet</city>
        <zip>6000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zsolt Horvath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz</name>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamas Babicz</last_name>
      <phone>+3642599700</phone>
      <phone_ext>1895</phone_ext>
      <email>dr.babicz.tamas@szszbmk.hu</email>
    </contact>
    <contact_backup>
      <last_name>Klara Mezei</last_name>
      <phone>+3642599700</phone>
      <email>mezeiklara62@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jozsef Erfan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tolna Megyei Balassa Janos Korhaz Onkologiai Osztaly</name>
      <address>
        <city>Szekszard</city>
        <zip>7100</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Yousuf Al-Farhat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASL Regionale Piemonte - Ospedale Santo Spirito Casale Monferrato (Ospedale di Casale Monferrato)</name>
      <address>
        <city>Casale Monferrato</city>
        <state>Alessandria</state>
        <zip>15033</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberta Buosi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Cagliari- P.O. Policlinico Universitario Duilio Casula</name>
      <address>
        <city>Monserrato</city>
        <state>Cagliari</state>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mario Scartozzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Centro di Riferimento Oncologico</name>
      <address>
        <city>Aviano</city>
        <state>Pordenone</state>
        <zip>33081</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Angela Buonadonna</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico Tor Vergata</name>
      <address>
        <city>Rome</city>
        <state>Roma</state>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Vincenzo Formica</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</name>
      <address>
        <city>Rome</city>
        <state>Roma</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giampaolo Tortora</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale P. Pederzoli - Casa di Cura Privata Spa Presidio Ospedaliero ULSS 9 - Scaligera</name>
      <address>
        <city>Peschiera del Garda</city>
        <state>Verona</state>
        <zip>37019</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Tosoni</last_name>
      <phone>+39456449152</phone>
      <email>etosoni@ospedalepederzoli.it</email>
    </contact>
    <investigator>
      <last_name>Felice Pasini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Cremona</city>
        <zip>26100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michele Ghidini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lorenzo Antonuzzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Leo Silvana</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Nazionale dei Tumori</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Maria Di Bartelomeo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria- Università degli Studi della Campania &quot;Luigi Vanvitelli&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Fortunato Ciardiello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Bianchi Melacrino Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <zip>89124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Pierpaolo Correale</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Campus Bio-Medico di Roma</name>
      <address>
        <city>Roma</city>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Emanuela Dell'Aquila</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Città della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Patrizia Racca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bialostockie Centrum Onkologii im.M.Sklodowskiej-Curie</name>
      <address>
        <city>Bialystok</city>
        <zip>15-027</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marek Wojtukiewicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpitale Pomorskie spółka z ograniczoną odpowiedzialnością</name>
      <address>
        <city>Gdynia</city>
        <zip>81-519</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Drezek</last_name>
      <phone>+48587260380</phone>
      <email>kdrezek@szpitalepomorskie.eu</email>
    </contact>
    <contact_backup>
      <last_name>Aleksandra Rukasz-Davies</last_name>
      <phone>+48587260380</phone>
      <email>arukasz@szpitalepomorskie.eu</email>
    </contact_backup>
    <investigator>
      <last_name>Iwona Danielewicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpital Specjalistyczny im. L.Rydygiera w Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-637</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Piotr Koralewski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli</name>
      <address>
        <city>Lublin</city>
        <zip>20-090</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Agata Chrzanowska-Kapica</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mrukmed Lekarz Beata Madej Mruk i Partner Spółka Partnerska Oddział nr 1 w Rzeszowie</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-922</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michal Hapka</last_name>
      <phone>+48178502470</phone>
      <email>hapka.mrukmed@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ewelina Knurek</last_name>
      <phone>+48178502470</phone>
      <email>knurek.mrukmed@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Andrzej Mruk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Poznan</name>
      <address>
        <city>Skórzewo</city>
        <zip>60-185</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Piotr Tomczak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pratia MCM Krakow</name>
      <address>
        <city>Sucha Beskidzka</city>
        <zip>34-200</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bozena Cybulska-Stopa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Zdrowia MDM</name>
      <address>
        <city>Warszawa</city>
        <zip>00-635</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Krzysztof Jeziorski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lucjan Wyrwicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dolnoslaskie Centrum Onkologii</name>
      <address>
        <city>Wroclaw</city>
        <zip>53-413</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Piotr Hudziec</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onkologicky ustav svatej Alzbety s.r.o.</name>
      <address>
        <city>Bratislava</city>
        <zip>55131</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Peter Zuzak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univerzitna nemocnica s poliklinikou, Milosrdni bratia, spol. s.r.o. Onkologicke oddelenie</name>
      <address>
        <city>Bratislava</city>
        <zip>81465</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Miriam Drahokoupilova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vychodoslovensky onkologicky ustav, a.s.</name>
      <address>
        <city>Kosice</city>
        <zip>04191</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Igor Andrasina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fakultna nemocnica s poliklinikou J.A. Reimana Presov Oddelenie klinickej onkologie</name>
      <address>
        <city>Presov</city>
        <zip>081 81</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jaroslava Leskova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fakultna nemocnica Trnava</name>
      <address>
        <city>Trnava</city>
        <zip>91775</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Marian Stresko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Orense</name>
      <address>
        <city>Ourense</city>
        <state>Orense</state>
        <zip>32005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Pilar Fernandez Arias</last_name>
      <phone>+34988385471</phone>
      <email>maria.pilar.fernandez.arias@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Ariadna Mato Montero</last_name>
      <phone>+34988385471</phone>
      <email>ariadna.mato@iigaliciasur.es</email>
    </contact_backup>
    <investigator>
      <last_name>Mercedes Salgado Fernandez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susana Galtés</last_name>
      <phone>+34932483860</phone>
      <email>onco0901@parcdesalutmar.cat</email>
    </contact>
    <investigator>
      <last_name>Joana Vidal Barrull</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debora Cabot Romero</last_name>
      <phone>+34934894375</phone>
      <email>dcabot@vhio.net</email>
    </contact>
    <investigator>
      <last_name>Francesc Salva Ballabrera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Sanchez Gracia</last_name>
      <phone>+34932746085</phone>
      <email>sanchez14@clinic.cat</email>
    </contact>
    <contact_backup>
      <last_name>Marta Vano</last_name>
      <phone>+34932275400</phone>
      <email>qlq@clinic.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Joan Maurel Santasusana</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICO l'Hospitalet - Hospital Duran i Reynals</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesc Torrent Llagostera</last_name>
      <phone>+34933357011</phone>
      <email>ftorrent@idibell.cat</email>
    </contact>
    <investigator>
      <last_name>Mercedes Martinez Villacampa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Rodriguez</last_name>
      <phone>+34958020234</phone>
      <email>i_rodriguez_gonzalez@hotmail.es</email>
    </contact>
    <contact_backup>
      <last_name>Rosa MaGarrido Perez</last_name>
      <phone>+34606051432</phone>
      <email>rosamgarrido@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Encarnacion Gonzalez Flores</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Martinez</last_name>
      <phone>+34973003754</phone>
      <email>eoncolleida@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Joel Salla</last_name>
      <phone>+34973003754</phone>
      <email>jsalla@irblleida.cat</email>
    </contact_backup>
    <investigator>
      <last_name>Antonieta Salud Salvia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Lucus Augsti</name>
      <address>
        <city>Lugo</city>
        <zip>27003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Romero Van der Schoot</last_name>
      <phone>+34982296459</phone>
      <email>raquel.romero.van.der.schoot@sergas.es</email>
    </contact>
    <investigator>
      <last_name>Alberto Carral Maseda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Perez</last_name>
      <phone>+34914269629</phone>
      <email>mperez.hgugm@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ines Perez de la Fuente</last_name>
      <phone>+34914269629</phone>
      <email>i.pzfuente@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Pilar Garcia Alfonso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Aragoneses Lopez</last_name>
      <phone>+34913368263</phone>
      <email>sara.aragoneses@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Mario Cano Sanchez</last_name>
      <phone>+34913368263</phone>
      <email>enfermeriaensayoshryc@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Reyes Ferreiro Monteagudo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Marrugal Lorenzo</last_name>
      <phone>+34913908926</phone>
      <email>ammarrugal.imas12@h12o.es</email>
    </contact>
    <contact_backup>
      <last_name>Marta Carrasco Huelves</last_name>
      <phone>+34913908926</phone>
      <email>mcarrasco.imas12@h12o.es</email>
    </contact_backup>
    <investigator>
      <last_name>Cristina Gravalos Castro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Arriazu Galindo</last_name>
      <phone>34917277516</phone>
      <email>marioalapaz@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Pilar Boyero Hernandez</last_name>
      <phone>34917277516</phone>
      <email>pilarboyero@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nuria Rodriguez Salas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario HM Madrid Sanchinarro</name>
      <address>
        <city>Madrid</city>
        <zip>28050</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro Majadahonda</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rocío Navarro</last_name>
      <phone>+34911917147</phone>
      <email>rocio.navarro@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Maite Artero Morales</last_name>
      <phone>+34911917509</phone>
      <email>martero@idiphim.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ana Ruiz Casado</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Malaga</name>
      <address>
        <city>Malaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Lopez</last_name>
      <phone>+34951291425</phone>
      <email>sabrina.lopez@ibima.eu</email>
    </contact>
    <contact_backup>
      <last_name>Maria Valbuena</last_name>
      <phone>+34951291425</phone>
      <email>maria.valbuena.eecc@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Silvia Gil Calle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Suengas</last_name>
      <phone>+34955926578</phone>
      <email>moni.suengas@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Eduardo Montilla Burgos</last_name>
      <phone>+34600162143</phone>
      <email>dvicentebaz@yahoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Juan Jose Reina Zoilo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Robles</last_name>
      <phone>+34955013068</phone>
      <email>i.robles.huvr@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Rojas</last_name>
      <phone>+34955013068</phone>
      <email>enfermeriaensayosclinicoshvr@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Maria Luisa Limon Miron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celia Martinez</last_name>
      <phone>+34961973528</phone>
      <email>cmartinez@incliva.es</email>
    </contact>
    <contact_backup>
      <last_name>Luna Porta Campos</last_name>
      <phone>+34961973527</phone>
      <email>lporta@incliva.es</email>
    </contact_backup>
    <investigator>
      <last_name>Susana Rosello Keranen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicia Guerrero</last_name>
      <phone>+31402279022</phone>
      <email>aguerrero.miguelservet@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Concepcion Velazquez</last_name>
      <phone>+31402279022</phone>
      <email>cvelazquez.miguelservet@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Eduardo Polo Marques</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CI Cherkasy Regional Oncological Dispensary of CRC</name>
      <address>
        <city>Cherkasy</city>
        <zip>18009</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anastasiia Yaremenko</last_name>
      <phone>+380636152078</phone>
      <email>nyaremenko96@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Viktor Paramonov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MI Regional Clinical Oncologycal Dispensary</name>
      <address>
        <city>Dnipro</city>
        <zip>49100</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nataliia Zvonarova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dnipropetrovsk City Multispecialty Clinical Hospital #4</name>
      <address>
        <city>Dnipro</city>
        <zip>49102</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yana Sukhoversha</last_name>
      <phone>+3802062886355</phone>
      <email>sukhovershayana@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Igor Bondarenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Limited Liability Company &quot;Medical Center named by Academician Yuriy Prokopovich Spizhenko&quot;</name>
      <address>
        <city>Kapitanivka</city>
        <zip>8112</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Valerii Cheshuk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 of KCC</name>
      <address>
        <city>Kharkiv</city>
        <zip>61037</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergii Posokhov</last_name>
      <phone>+380982824470</phone>
      <email>posohovsn30@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Olena Datsenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv NMU</name>
      <address>
        <city>Kharkiv</city>
        <zip>61070</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liudmyla Krasna</last_name>
      <phone>+380573151248</phone>
      <email>lyudmila.krasna@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Denys Skoryi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CI of Healthcare Regional Clinical Specialized Dispensary of the Radiation Protection</name>
      <address>
        <city>Kharkiv</city>
        <zip>61166</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Oleksandr Dudnichenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CI Kryvyi Rih Oncological Dispensary of DRC</name>
      <address>
        <city>Kryvyi Rih</city>
        <zip>50048</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hryhoriy Adamchuk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyiv Сity Clinical Oncological Center</name>
      <address>
        <city>Kyiv</city>
        <zip>03115</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Olga Ponomarova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Communal Enterprise Volyn Regional Medical Center of Oncology of Volyn Regional Council</name>
      <address>
        <city>Lutsk</city>
        <zip>43018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ivan Sinielnikov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LISOD Hospital of Israeli Oncology</name>
      <address>
        <city>Obukhiv</city>
        <zip>08720</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dinara Ryspayeva</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Communal Institution Odesa Regional Clinical Hospital; Department of Surgery</name>
      <address>
        <city>Odesa</city>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yurii Osypchuk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Sumy State University</name>
      <address>
        <city>Sumy</city>
        <zip>40022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vitaliia Kostiuchenko</last_name>
      <phone>+380957458303</phone>
      <email>vitaliiakos@ukr.net</email>
    </contact>
    <investigator>
      <last_name>Ihor Vynnychenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Communal Enterprise Kremenchuk Regional Oncology Dispensary of Poltava Regional Council</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>39617</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Oleksandr Koshelenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CI Zaporizhzhia Regional Clinical Oncological Dispensary of ZRC Thoracic Department</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69040</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Oleksandr Goloborodko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical center &quot;Oncolife&quot; LLC</name>
      <address>
        <city>Zaporizhzhia</city>
        <zip>69059</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kateryna Kotelevets</last_name>
      <phone>+380507841168</phone>
      <email>kotelevets15@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Oleksii Kolesnik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Torbay Hospital</name>
      <address>
        <city>Torquay</city>
        <state>Devon</state>
        <zip>TQ2 7AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lo Nangi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barts Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David Propper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel Krell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christie</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Breeze</last_name>
      <email>michael.breeze@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Saifee Mullamitha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Velindre Cancer Centre</name>
      <address>
        <city>Cardiff</city>
        <state>South Glamorgan</state>
        <zip>CF14 2TL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Jackson</last_name>
      <phone>+4412920615888</phone>
      <email>amanda.jackson2@wales.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Colette Kemp</last_name>
      <email>colette.kemp@wales.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal Cancer</keyword>
  <keyword>mCRC</keyword>
  <keyword>colon</keyword>
  <keyword>chemotherapy-induced myelosuppression</keyword>
  <keyword>chemotherapy-induced neutropenia</keyword>
  <keyword>chemotherapy-induced anemia</keyword>
  <keyword>CDK 4/6 inhibitor</keyword>
  <keyword>trilaciclib</keyword>
  <keyword>FOLFOXIRI</keyword>
  <keyword>bevacizumab</keyword>
  <keyword>myelosuppression</keyword>
  <keyword>cyclin-dependent kinase 4/6 inhibitor</keyword>
  <keyword>myelopreservation</keyword>
  <keyword>rectum</keyword>
  <keyword>Preserve</keyword>
  <keyword>PRESERVE 1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

